Correlation Between CF Acquisition and Deep Medicine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CF Acquisition and Deep Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CF Acquisition and Deep Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CF Acquisition VII and Deep Medicine Acquisition, you can compare the effects of market volatilities on CF Acquisition and Deep Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CF Acquisition with a short position of Deep Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of CF Acquisition and Deep Medicine.

Diversification Opportunities for CF Acquisition and Deep Medicine

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between CFFS and Deep is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding CF Acquisition VII and Deep Medicine Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Deep Medicine Acquisition and CF Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CF Acquisition VII are associated (or correlated) with Deep Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Deep Medicine Acquisition has no effect on the direction of CF Acquisition i.e., CF Acquisition and Deep Medicine go up and down completely randomly.

Pair Corralation between CF Acquisition and Deep Medicine

Given the investment horizon of 90 days CF Acquisition is expected to generate 4.35 times less return on investment than Deep Medicine. But when comparing it to its historical volatility, CF Acquisition VII is 6.21 times less risky than Deep Medicine. It trades about 0.1 of its potential returns per unit of risk. Deep Medicine Acquisition is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  1,019  in Deep Medicine Acquisition on September 6, 2024 and sell it today you would earn a total of  140.00  from holding Deep Medicine Acquisition or generate 13.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy30.36%
ValuesDaily Returns

CF Acquisition VII  vs.  Deep Medicine Acquisition

 Performance 
       Timeline  
CF Acquisition VII 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CF Acquisition VII are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, CF Acquisition is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Deep Medicine Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Deep Medicine Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Deep Medicine is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

CF Acquisition and Deep Medicine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CF Acquisition and Deep Medicine

The main advantage of trading using opposite CF Acquisition and Deep Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CF Acquisition position performs unexpectedly, Deep Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deep Medicine will offset losses from the drop in Deep Medicine's long position.
The idea behind CF Acquisition VII and Deep Medicine Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum